Abstract:Objective: To observe the clinical effect of Huoxue Tongyu decoction combined with TCM syndrome differentiation in the treatment of patients with ovulatory infertility. Methods: 98 patients with ovulatory infertility in our hospital from Feb. 2016 to Apr. 2017 were selected as the study objects, and they were randomly divided into control group and observation group, with 49 cases in each group. The control group was treated with western medicine, and the observation group was treated with Huoxue Tongyu decoction combined with TCM syndrome differentiation. The oviposit rates and pregnancy rates of different duration of disease, diameter of follicle and the thickness of endometrium before and after the treatment of two groups were compared. Results: The oviposit rates and pregnancy rates of observation group with different duration of disease were all higher than those of control group, the differences were statistically significant (P<0.05). The diameter of follicle and the thickness of endometrium of two groups before the treatment were compared, and the differences were not statistically significant (P>0.05). The diameter of follicle and the thickness of endometrium of observation group were all higher than those of control group, the differences were statistically significant (P<0.05). Conclusion: The clinical effect of Huoxue Tongyu decoction combined with TCM syndrome differentiation in the treatment of patients with ovulatory infertility is better, and it can significantly improve the oviposit rate and pregnancy rate.
[1] 崔丽.补肾活血方案治疗排卵障碍性不孕不育的多中心随机双盲对照临床研究[J].实用妇科内分泌杂志(电子版),2016,3(4):27~30. [2] 全莉梅.益肾活血汤联合氯米芬治疗多囊卵巢综合征排卵障碍性不孕36例观察[J].浙江中医杂志,2017,52(4):265. [3] 罗岚,陈淑琼.补肾活血法治疗排卵障碍性不孕的Meta分析[J].世界中西医结合杂志,2015,(3):300~303,377. [4] 金炫廷,马堃,单婧,等.补肾活血中药治疗多囊卵巢综合征导致排卵障碍性不孕的临床研究[J].中国中药杂志,2014,39(1):140~143. [5] 南风艳.中西医结合治疗排卵功能障碍性不孕症临床分析[J].世界中医药,2015,(1):63~66. [6] 葛华,陈宣伊,梁国强等.中西医结合治疗排卵障碍性不孕症临床观察[J].中国基层医药,2016,23(2):245~248. [7] 安芳,张帅.中西医结合治疗排卵障碍性不孕症临床研究[J].河南中医,2016,36(10):1816~1818. [8] Rashidi BH,Gorginzadeh M, Aalipour S, et al. Age related endocrine patterns observed in polycystic ovary syndrome patients vs. ovulatory controls: descriptive data from a university based infertility center[J]. Arch Endocrinol Metab, 2016, 60(5): 486~491. [9] Lie Fong S, Laven JSE, Duhamel A, et al. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Mullerian hormone using cluster analysis[J]. Hum Reprod, 2017, 32(8):1723~1731.